Certified by Founder Lodge
Third Rock Ventures
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets operational
Company | Date | Round | Raised |
---|---|---|---|
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
CARGO Therapeutics | March, 06 ,2023 | Series A | $200,000,000 |
ARTBIO | December, 08 ,2023 | Series A | $90,000,000 |
Rapport Therapeutics | March, 08 ,2023 | Series A | $100,000,000 |
Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
Flare Therapeutics | March, 23 ,2023 | Series B | $123,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Marea Therapeutics | June, 20 ,2024 | Series A | $190,000,000 |
ARTBIO | December, 08 ,2023 | Series A | $90,000,000 |
Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
Marea Therapeutics | June, 20 ,2024 | Series A | $190,000,000 |
Maze Therapeutics | December, 04 ,2024 | Series D | $115,000,000 |